Hypercell Technologies was founded with the core mission of proactively controlling infectious diseases in animals to prevent future pandemics in humans. The company focuses on developing rapid point-of-care diagnostic tools for the early identification and management of biological contaminants within the food chain, from production to transformation. Their market focus includes the agricultural and food production industries, aiming to mitigate the $10 billion annual loss in productivity due to animal diseases and reduce the risk of zoonotic disease transmission to humans.

Notable affiliated people include experts in veterinary science and biotechnology, although specific names are not provided. Hypercell Technologies has partnered with key stakeholders in the food production industry to enhance the impact of their diagnostic tools. Key achievements include the development of innovative diagnostic solutions that have significantly improved the early detection and management of infectious diseases in production animals. Overall, Hypercell Technologies has made a substantial impact on both animal health and public health by addressing critical gaps in disease control within the food supply chain.